8 followers
Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines.
John Evans
Gilead Sciences
135 followers
Verily Life Sciences
38 followers
BioMarin Pharmaceutical
36 followers
Sarepta Therapeutics
9 followers
PerkinElmer
9 followers
Oxford Nanopore Technologies
8 followers
United Therapeutics
8 followers
Murad
5 followers
AGC Biologics
4 followers
Summit Therapeutics
4 followers
Merck
228 followers
Explore companies